Birdwatch Note
2024-12-06 03:30:40 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
帯状疱疹ワクチン・シングリックスでは発症予防効果97%程度である事が報告済です（下記6p)。 https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000207078.pdf なお、帯状疱疹は、コロナワクチン接種者や接種直後に微妙な客観的医療記録の増加があるかはそれが確認されたメタ解析もあったのですが、 https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2232451 その後の最新のメタ解析ではリスクが検出できていない事にも注意が必要です。 https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.29629?casa_token=vpluIDNnCLkAAAAA%3AFnn9R-w0288jz0apVwEhVuK5MUIr8UPs9xsjeaUgSPUqSd1QtuWezEcA3WPExdHOeuprQoF4lAV2Vvuw また、帯状疱疹は初診患者数としても21年,22年にコロナ禍前より減少しています(下記２つめの図)。 https://web.archive.org/web/20230725185950/https://news.yahoo.co.jp/articles/6ca1c6739b46d8201f28467a56bfd773cc2332af
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1864831668424753452
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1864875075222245689
- noteId - 1864875075222245689
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1733455840293
- tweetId - 1864831668424753452
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 帯状疱疹ワクチン・シングリックスでは発症予防効果97%程度である事が報告済です（下記6p)。 https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000207078.pdf なお、帯状疱疹は、コロナワクチン接種者や接種直後に微妙な客観的医療記録の増加があるかはそれが確認されたメタ解析もあったのですが、 https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2232451 その後の最新のメタ解析ではリスクが検出できていない事にも注意が必要です。 https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.29629?casa_token=vpluIDNnCLkAAAAA%3AFnn9R-w0288jz0apVwEhVuK5MUIr8UPs9xsjeaUgSPUqSd1QtuWezEcA3WPExdHOeuprQoF4lAV2Vvuw また、帯状疱疹は初診患者数としても21年,22年にコロナ禍前より減少しています(下記２つめの図)。 https://web.archive.org/web/20230725185950/https://news.yahoo.co.jp/articles/6ca1c6739b46d8201f28467a56bfd773cc2332af
Note Ratings
| rated at | rated by | |
| 2024-12-06 11:00:26 -0600 | Rating Details | |
| 2024-12-06 08:13:05 -0600 | Rating Details | |
| 2024-12-06 04:19:41 -0600 | Rating Details | |
| 2024-12-06 01:50:01 -0600 | Rating Details | |
| 2024-12-06 01:29:44 -0600 | Rating Details | |
| 2024-12-06 01:19:02 -0600 | Rating Details | |
| 2024-12-06 00:12:58 -0600 | Rating Details | |
| 2024-12-06 00:07:27 -0600 | Rating Details | |
| 2024-12-05 23:56:06 -0600 | Rating Details | |
| 2024-12-05 23:10:22 -0600 | Rating Details | |
| 2024-12-05 23:06:42 -0600 | Rating Details | |
| 2024-12-05 22:52:42 -0600 | Rating Details | |
| 2024-12-05 22:30:03 -0600 | Rating Details | |
| 2024-12-05 21:56:43 -0600 | Rating Details | |
| 2024-12-05 21:48:51 -0600 | Rating Details | |
| 2024-12-05 21:47:34 -0600 | Rating Details | |
| 2024-12-05 21:35:41 -0600 | Rating Details | |
| 2024-12-05 21:35:01 -0600 | Rating Details | |
| 2024-12-06 20:16:57 -0600 | Rating Details | |
| 2024-12-06 03:11:40 -0600 | Rating Details | |
| 2024-12-06 00:49:06 -0600 | Rating Details | |
| 2024-12-05 23:08:01 -0600 | Rating Details | |
| 2024-12-05 22:07:08 -0600 | Rating Details | |
| 2024-12-05 21:58:53 -0600 | Rating Details | |
| 2024-12-10 06:49:34 -0600 | Rating Details | |
| 2024-12-06 21:40:28 -0600 | Rating Details | |
| 2024-12-06 16:43:32 -0600 | Rating Details | |
| 2024-12-06 10:04:00 -0600 | Rating Details | |
| 2024-12-06 04:06:38 -0600 | Rating Details | |
| 2024-12-05 22:59:14 -0600 | Rating Details | |
| 2024-12-05 22:35:17 -0600 | Rating Details | |
| 2024-12-05 22:33:25 -0600 | Rating Details | |
| 2024-12-05 22:30:40 -0600 | Rating Details | |
| 2024-12-05 22:06:35 -0600 | Rating Details | |
| 2024-12-05 21:55:48 -0600 | Rating Details | |
| 2024-12-10 05:31:34 -0600 | Rating Details | |
| 2024-12-08 23:09:39 -0600 | Rating Details | |
| 2024-12-07 23:56:45 -0600 | Rating Details | |
| 2024-12-06 05:12:39 -0600 | Rating Details | |
| 2024-12-06 01:53:14 -0600 | Rating Details | |
| 2024-12-06 00:45:33 -0600 | Rating Details | |
| 2024-12-05 23:08:15 -0600 | Rating Details | |
| 2024-12-05 22:54:04 -0600 | Rating Details | |
| 2024-12-05 21:57:18 -0600 | Rating Details | |
| 2024-12-05 21:55:17 -0600 | Rating Details |